Director, Global Real-World Evidence & Health Outcomes Research Scientist, Hematology-Oncology

GSK•Philadelphia, PA

5d•Hybrid

About The Position

The role of Director, Global Real-World Evidence & Health Outcomes Research Scientist Hematology-Oncology ensures that each medicine GSK brings to market is supported by scientifically credible, high quality evidence that drives competitiveness and strong evidence-based product positioning, value propositions, and value-based pricing. The role is critical to support the alignment of evidence with evidentiary requirements of customers responsible for marketing authorization, recommendation and reimbursement leading to successful patient access, product use, and commercial success. This role promises a fast-paced environment supporting a new-to-market product in a dynamic hematology space. This role will provide YOU the opportunity to lead key activities to progress YOUR career.

Requirements

MSc, or equivalent in health outcomes, health economics, epidemiology, pharmacy, health or life sciences.
3+ years of experience working in the pharmaceutical industry, preferably in a multi-national company.
Experience in planning and delivering individual projects, managing budgets and working within a matrix setting.
A history of designing a variety of RWE studies including prospective observational studies, cross-sectional and retrospective cohort studies, chart reviews, and database analyses.
Proficiency in utilizing evidence for the development of HTA submissions, reimbursement and/or medical engagements.
A track record of delivering robust payer evidence and credibility to engage meaningfully with external experts and leaders in the field.
Expertise with the diversity and complexity of healthcare markets, health technology assessment agencies, and reimbursement decision making globally, in region and local markets.
Experience in communicating technical and complex concepts and results to various audiences to impact decision-making.
Experience in oncology or hematology.

Nice To Haves

Advanced scientific degree, e.g. PhD, PharmD, or equivalent in Health Economics, Outcomes Research, Epidemiology, or similar.
Experience working in a Global role.
Experience working on a launch brand.
Experience working in hematology.

Responsibilities

Plan, design, and execute multiple studies for a given asset and manage timelines, deliverables, and budget.
Assure quality of deliverables, including review and sign off project specifications, protocols, data analysis plans, final study reports, abstracts, posters and manuscripts, in adherence to SOPs.
Identify resources, references and analyses to inform scientific design and advise internal experts (medical affairs, clinical, commercial/market access) and external experts as needed in support of the asset team.
Translate needs for evidence into study concepts in alignment with strategic objectives and vision for the asset, e.g. development of study protocols and proposing innovative and cost-effective ways of developing and executing studies.
Develop and maintain a good working knowledge of real-world data resources, existing partnerships and public initiatives and become the point person for select sources to advise on their suitability to address given research questions.
Develop a deep understanding of customers’ needs, including clinicians and HTA requirements, and their acceptance of different types of evidence and impact of that evidence to their decision making.
Collaborate with internal teams and participate in best practice sharing sessions across the non-interventional study organization.
Build strong working relationships with internal stakeholder groups across medical, market access, R&D and commercial to ensure strategic alignment and optimal cross-functional collaboration and communication.
Ensure key stakeholders, including TA aligned business leaders, are regularly updated on plans through periodic reporting.
Develop excellent working relationships with external thought leaders to ensure appropriate methods and research agendas are applied, in accordance with GSK policies.